Passage Bio (PASG)
(Delayed Data from NSDQ)
$1.35 USD
+0.04 (3.05%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $1.39 +0.04 (2.96%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth A Momentum B VGM
Brokerage Reports
Passage Bio, Inc. [PASG]
Reports for Purchase
Showing records 1 - 20 ( 43 total )
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
Key Readout In FTD Draws Closer, Amidst Inline 3Q23 Report
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
Updated GM1 Data Appears Positive, Dose 3 Underway [2Q23 Highlights]
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
Live To Fight Another Day -- Workforce Reduction Provides Cash Runway Extension
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
With Efforts Rolling Along, Looking Ahead To 2H23 Data Readouts
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
Notes From The (Virtual) Road... Fresh Visits With New Management
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Passage Bio, Inc.
Industry: Medical - Biomedical and Genetics
Pipeline Prioritization, Streamlining Necessary For Advancement
Provider: Wedbush Securities Inc.
Analyst: CHICO L